About Laekna Therapeutics

Founded in December 2016, Laekna Therapeutics is an innovative emerging Biotech company based in China’s “Zhangjiang Pharma Valley” and in New Jersey in the US, focused on developing ground-breaking innovative therapeutics to treat cancer and liver diseases.

Laekna Therapeutics is adopting a two-pronged strategy in new drug development. First, it continues to enrich its portfolio by introducing new drugs with the clinical Proof of Concept. The company has obtained the exclusive global rights of four new drug candidates from Novartis. In addition, the company has established internal discovery platforms for cancer and liver diseases and will soon have self-developed candidates entering clinical stages.

Laekna has established a team of top global pharmaceutical talent and acquired key technologies. Its leadership team has over 20 years of experience in new drug development in China and the US, with an exceptional track record in R&D, new drug approvals and commercialization. In order to benefit patients, Laekna is committed to a science-based, innovation-driven approach to creating a leading clinical research and development pipeline, and developing first-in-class and best-in-class innovative drugs.

The detail Laekna Therapeutics information can be found from the website: http://www.leaknatp.com.

Job Summary:

The candidate will be responsible to develop, plan and execute an IR strategic plan and oversee the overall IR function.

A qualified candidate should be a corporate professional who also has entrepreneurial skills and is able to keep high levels of professionalism when dealing with investors and stake holders as the company proceeds through both positive and negative developments.

Success in this role requires collaboration, communication, leadership, vision, and resolve.

Responsibilities

Acting as a key person in IPO and head capital market operation after listing. 

Working closely with the finance and operation team to create a story/angle to properly present to external stakeholders about the company and industry outlook.

Coordinate across functional teams, such as finance, legal, R&D to gather information in preparation for quarterly report and executive presentations.

Acting as the key focal point for potential international investors, and responsible for driving and facilitating analyst meetings, roadshows.

Maintaining a close relationship with other internal / external stakeholders like CEO, CFO and equity research analysts to ensure a good grasp of market insights, competitor's landscape.

Help prepare the company’s press releases and financial filings and coordinate with our legal & communication team to strategize the best release timing of our news and announcement. 

Analyze the business landscape and trend of the industry, providing updates of the company on strategic positioning and business development to investors through creation of FAQs or other ad hoc projects

Qualifications:

Bachelor degree or above in science, business or finance

5-10 years’ experience of in-house corporate investor relations, or have proven experience on the buy or sell-side in investment bank with strong technology skills and a desire to learn IR

Knowledge in the overall HK-Share market

Familiarity with China HK-share filings requirements 

Excellent written and verbal communication skills, including ability to draft engaging and concise messages for investor presentations 

Familiarity with financial modeling techniques and valuation methods used by analysts and investors

Previous experience in practicing as an information disclosure presentative for HK-Share listed companies will be preferred

Knowledge of and familiarity with the capital markets, as well as an understanding of key metrics for companies in the biotechnology industry is a plus

A good team player, ability to perform in a high-pressure environment, and meet tight deadlines

Laekna Therapeutics is an equal opportunity/affirmative action employer. All qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.